M K Lynn, Hunter M Boehme, Jeffrey Hall, Patrick Kent, Alain H Litwin, Quang H Pham, Melissa S Nolan
{"title":"An Evidence-Based Intervention to Increase <i>Trypanosoma cruzi</i>, a Neglected Parasitic Infection, Diagnosis in Rural and Moderate-Size-City US Clinics.","authors":"M K Lynn, Hunter M Boehme, Jeffrey Hall, Patrick Kent, Alain H Litwin, Quang H Pham, Melissa S Nolan","doi":"10.1093/ofid/ofaf467","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chagas disease is a chronic, insidious parasitic infection (<i>Trypanosoma cruzi</i>) that slowly develops to irreversible organomegaly over several decades. The disease is traditionally acquired in endemic Latin American countries during childhood; <1% of foreign-born adult residents in the United States have been diagnosed or treated with this potentially fatal disease. Low physician knowledge is a primary factor leading to misdiagnosis.</p><p><strong>Methods: </strong>Starting in April 2022, a 4-part <i>T cruzi</i> clinical education intervention began, which included (<i>i</i>) 2 grand rounds presentations to >100 internal medicine providers; (<i>ii</i>) implementation of a \"clinical Chagas champions program\" incorporating 14 key clinical staff at varying departments and administrative levels educated on their specific role related to <i>T cruzi</i> screening, diagnosis confirmation, clinical management, and medical billing; (<i>iii</i>) connecting clinicians with external, experienced providers to provide guidance during the medically challenging treatment process; and (<i>iv</i>) <i>T cruzi</i> patient screening at Prisma Health hospitals, family medicine clinics, or affiliated free health clinics. The program's long-term impact was evaluated using a panel Poisson time series statistical model of ordered tests pre- and post-intervention.</p><p><strong>Results: </strong>For the healthcare system screening initiative, 71 participants were enrolled from across Prisma Health's 21-county region, with a 2.9% Chagas disease seroprevalence detected. Time series analysis of <i>T cruzi</i> testing orders within the healthcare system demonstrated a statistically significant increase in ordered tests across the 30 months post-intervention compared to the 51 months prior.</p><p><strong>Conclusions: </strong>This intervention substantiates the need to pair academic-health partnerships and clinical awareness campaigns to sustainably support long-term <i>T cruzi</i> screening in nontraditional areas.</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"12 8","pages":"ofaf467"},"PeriodicalIF":3.8000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12372667/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Forum Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ofid/ofaf467","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Chagas disease is a chronic, insidious parasitic infection (Trypanosoma cruzi) that slowly develops to irreversible organomegaly over several decades. The disease is traditionally acquired in endemic Latin American countries during childhood; <1% of foreign-born adult residents in the United States have been diagnosed or treated with this potentially fatal disease. Low physician knowledge is a primary factor leading to misdiagnosis.
Methods: Starting in April 2022, a 4-part T cruzi clinical education intervention began, which included (i) 2 grand rounds presentations to >100 internal medicine providers; (ii) implementation of a "clinical Chagas champions program" incorporating 14 key clinical staff at varying departments and administrative levels educated on their specific role related to T cruzi screening, diagnosis confirmation, clinical management, and medical billing; (iii) connecting clinicians with external, experienced providers to provide guidance during the medically challenging treatment process; and (iv) T cruzi patient screening at Prisma Health hospitals, family medicine clinics, or affiliated free health clinics. The program's long-term impact was evaluated using a panel Poisson time series statistical model of ordered tests pre- and post-intervention.
Results: For the healthcare system screening initiative, 71 participants were enrolled from across Prisma Health's 21-county region, with a 2.9% Chagas disease seroprevalence detected. Time series analysis of T cruzi testing orders within the healthcare system demonstrated a statistically significant increase in ordered tests across the 30 months post-intervention compared to the 51 months prior.
Conclusions: This intervention substantiates the need to pair academic-health partnerships and clinical awareness campaigns to sustainably support long-term T cruzi screening in nontraditional areas.
期刊介绍:
Open Forum Infectious Diseases provides a global forum for the publication of clinical, translational, and basic research findings in a fully open access, online journal environment. The journal reflects the broad diversity of the field of infectious diseases, and focuses on the intersection of biomedical science and clinical practice, with a particular emphasis on knowledge that holds the potential to improve patient care in populations around the world. Fully peer-reviewed, OFID supports the international community of infectious diseases experts by providing a venue for articles that further the understanding of all aspects of infectious diseases.